卡塔尔波尔 (Catalpol):一种具有有前途的治疗性质的天然多功能虹膜糖化物
Guannan He1, Jing Song2, Ruixuan Ma1
1College of First Clinical Medical, Shandong University of Traditional Chinese Medicine, Jinan, China.
Frontiers in molecular biosciences
|March 6, 2026
概括
卡塔尔波尔 (Catalpol) 是来自Rehmannia glutinosa的化合物,具有广泛的治疗作用,包括器官保护和抗癌性质. 需要进一步的研究和临床试验才能充分理解它的机制和临床价值.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 传统中国医药 传统中国医药
背景情况:
- 卡塔尔波尔是来自Rehmannia glutinosa的一种关键的虹膜糖化物,对于质量评估至关重要.
- 自2005年以来,它是中国药典中公认的成分.
研究的目的:
- 审查catalpol的治疗作用和机制.
- 突出最近在catalpol药物输送和临床开发方面的进展.
主要方法:
- 在主要科学数据库 (Web of Science,PubMed) 和知识产权数据库中进行全面的文献搜索.
- 对过去5年的数据进行分析.
主要成果:
- 卡塔尔波尔证明了器官和组织保护作用 (脏,大脑,心脏等). 并表现出抗关节炎,抗癌和抗糖尿病的特性.
- 机制包括抗炎,抗氧化,抗亡,抗纤维和新陈代谢调节功能.
- 新的药物输送系统和新型"catalpol片"正在开发中,后者正在进入临床试验.
结论:
- 卡塔尔波尔具有复杂的分子机制介导的多种治疗潜力.
- 对其作用机制的进一步研究和广泛的临床试验对于验证其治疗价值至关重要.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
578
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
578
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
670
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
670
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.4K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
618
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
618
Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
584
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
584

